✦ LIBER ✦

Fluoxetine as an add-on medication to typical antipsychotics in chronic schizophrenia

✍ Scribed by C. Arango; B. Kirkpatrick; R.W. Buchanan

Book ID: 119554344
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 102 KB
Volume: 41
Category: Article
ISSN: 0920-9964
DOI: 10.1016/s0920-9964(00)90823-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ritanserin as add-on medication to neuro

Ritanserin as add-on medication to neuroleptic therapy for patients with chronic or subchronic schizophrenia

✍ J. A. Den Boer; J.-O. Vahlne; P. Post; A. H. Heck; F. Daubenton; R. Olbrich 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 980 KB

The effect of ritanserin, a potent 5HT 2A/2C receptor antagonist, used as an add-on medication to neuroleptic treatment in patients with schizophrenia, was compared with that of placebo, in an international, double-blind, parallel-group study. Previously established neuroleptic therapy was maintaine

Valproate semisodium [divalproex sodium]

Valproate semisodium [divalproex sodium] appears to be a beneficial add-on therapy to standard antipsychotics in patients with acute exacerbations of chronic schizophrenia

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 134 KB

Poster #S76 A RANDOMIZED TRIAL ADMINISTE

Poster #S76 A RANDOMIZED TRIAL ADMINISTERING RALOXIFENE VS PLACEBO AS ADD-ON TO ANTIPSYCHOTICS IN POST-MENOPAUSAL FEMALE PATIENTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER

✍ Burshtein, Shimon; Davidson, Michael; Weiser, Mark 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Granisetron as an add-on to risperidone

Granisetron as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study

✍ Khodaie-Ardakani, Mohammad-Reza; Seddighi, Sahar; Modabbernia, Amirhossein; Reza 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 368 KB

Eicosapentaenoic acid as an add-on to an

Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: A randomized, double-blind placebo-controlled study

✍ M. Bot; F. Pouwer; J. Assies; E.H.J.M. Jansen; M. Diamant; F.J. Snoek; A.T.F. Be 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Cost-effectiveness of roflumilast as an

Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom

✍ Samyshkin, Yevgeniy; Kotchie, Robert W.; Mörk, Ann-Christin; Briggs, Andrew H.; 📂 Article 📅 2013 🏛 Springer 🌐 French ⚖ 377 KB